𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1005 PARTIAL VIROLOGICAL RESPONSE TO ENTECAVIR IN TREATMENT-NAIVE CHRONIC HEPATITIS B: AN EVALUATION OF EASL GUIDELINE

✍ Scribed by Chon, Y.E.; Kim, S.U.; Park, J.Y.; Kim, D.Y.; Han, K.-H.; Chon, C.Y.; Moon, Y.M.; Ahn, S.H.

Book ID
123048865
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
53 KB
Volume
52
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Entecavir treatment for chronic hepatiti
Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naΓ―ve patients with a partial virological response
✍ Roeland Zoutendijk; JurriΓ«n G. P. Reijnders; Ashley Brown; Fabien Zoulim; David πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 315 KB πŸ‘ 1 views

Entecavir (ETV) is a potent inhibitor of viral replication in nucleos(t)ide analogue (NA)-naΓ―ve chronic hepatitis B (CHB) patients. The aim of this study was to investigate the long term efficacy and safety of ETV in NA-naΓ―ve CHB patients, particularly in those with detectable hepatitis B virus (HBV

Corrections: Entecavir treatment for chr
Corrections: Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naΓ―ve patients with a partial virological response
πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 55 KB πŸ‘ 1 views

In the August 2011 issue of HEPATOLOGY, in the article entitled ''Carcinogen-induced hepatic tumors in KLF6ΓΎ/Γ€ mice recapitulate aggressive human hepatocellular carcinoma associated with p53 pathway deregulation'' (volume 54, pages 522-531), Dr.